Search - tctmd.com

Displaying 1 - 20 of 66

Sort: Relevancy | Date

News Opinion Conversations in Cardiology

Conversations in Cardiology: Who Should Do TEE in Structural Heart Cases?

December 28, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2023

Shelley Wood

November 30, 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Shelley Wood

November 28, 2023

News Daily News

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

Michael O'Riordan

November 27, 2023

News Conference News PCR London Valves 2023

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

Shelley Wood

November 20, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

Clasp IID Updates and Complex Anatomy Registry

Presenter: Robert Smith

October 26, 2023

Presentation TCT 2023

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Presenter: Josep Rodés-Cabau

October 26, 2023

Presentation TCT 2023

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

Presenter: Suzanne Arnold

October 26, 2023

Presentation TCT 2023

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

Presenter: Vivek Reddy

October 26, 2023

News Conference News TCT 2023

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

Yael L. Maxwell

October 24, 2023

Presentation TCT 2023

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Presenter: Martin Leon

October 24, 2023

Presentation TCT 2023

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

Presenter: Raj Makkar

October 24, 2023

Presentation TCT 2023

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

Presenter: Omar Khalique

October 24, 2023

Advertisement

Conversations in Cardiology: Who Should Do TEE in Structural Heart Cases?

TCTMD’s Top 10 Most Popular Stories for November 2023

EuroSMR Score Outperforms Other Tools for M-TEER Risk Profiling

Ischemic Stroke After LAA Closure May Be Less Severe Than on DOACs

For the Ideal Tricuspid TEER Patient—Look Beyond TRILUMINATE

What’s Going to Be Hot at AHA 2023

TCTMD’s Top 10 Most Popular Stories for October 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Clasp IID Updates and Complex Anatomy Registry

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

LAAO as First Line Stroke Prevention Therapy: Are CHAMPION-AF and CATALYST Trials Likely to Succeed?

More TRILUMINATE Patients Flesh Out Tricuspid TEER’s Impact

The Future of Transcatheter Therapies for AR: The Impact of the ALIGN-AR Trial

Valve Hemodynamics and Device Performance: A New Era in Safety and Technical Success for TAVR in AR

Diving Deep into Pacemakers: Role of Oversizing, Implant Depth and Other Considerations from the CT Core Lab

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content